Propofol β-D-glucuronide (CAS 114991-26-3)
See product citations (3)
QUICK LINKS
Propofol β-D-glucuronide ,also know as Propofol Glucuronide, is a metabolite of Propofol, an extensively studied compound in the field of biochemistry. Research on Propofol β-D-glucuronide centers on its formation and excretion as it provides insights into the metabolic pathways of its parent compound. Investigations involve analyzing the role of glucuronidation, a major phase II metabolic reaction, in the biotransformation of Propofol by the uridine 5′-diphospho-glucuronosyltransferase (UGT) enzyme family. Additionally, the compound is used to study the efficiency of detoxification processes and the subsequent renal clearance of glucuronide conjugates. Propofol β-D-glucuronide′s solubility and polarity characteristics also make it a subject of interest in research on chemical metabolism and the factors that influence the kinetic profiles of anesthetics.
Propofol β-D-glucuronide (CAS 114991-26-3) References
- Propofol metabolites in man following propofol induction and maintenance. | Favetta, P., et al. 2002. Br J Anaesth. 88: 653-8. PMID: 12067002
- Biosynthesis of drug glucuronides for use as authentic standards. | Soars, MG., et al. 2002. J Pharmacol Toxicol Methods. 47: 161-8. PMID: 12628307
- Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. | Fujiwara, R., et al. 2007. Drug Metab Dispos. 35: 747-57. PMID: 17293379
- Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine. | Lee, SY., et al. 2012. J Chromatogr B Analyt Technol Biomed Life Sci. 900: 1-10. PMID: 22672847
- Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes. | Chen, A., et al. 2018. Toxicol Lett. 295: 379-389. PMID: 30036684
- Evaluation of the inhibition risk of shikonin on human and rat UDP-glucuronosyltransferases (UGT) through the cocktail approach. | Cheng, Y., et al. 2019. Toxicol Lett. 312: 214-221. PMID: 31128210
- Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes. | Choi, WG., et al. 2020. Pharmaceutics. 12: PMID: 32131538
- Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays. | Luo, H., et al. 2020. Regul Toxicol Pharmacol. 113: 104637. PMID: 32145316
- Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation. | Busse, D., et al. 2020. J Pharm Sci. 109: 2309-2320. PMID: 32294459
- Pharmacokinetics of α-amanitin in mice using liquid chromatography-high resolution mass spectrometry and in vitro drug-drug interaction potentials. | Park, R., et al. 2021. J Toxicol Environ Health A. 84: 821-835. PMID: 34187333
- Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs. | Tsamouri, MM., et al. 2022. Metabolites. 12: PMID: 35323643
- Toxicokinetics of β-Amanitin in Mice and In Vitro Drug-Drug Interaction Potential. | Bang, YY., et al. 2022. Pharmaceutics. 14: PMID: 35456608
- Biotransformation of Penindolone, an Influenza A Virus Inhibitor. | Liu, S., et al. 2023. Molecules. 28: PMID: 36771146
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Propofol β-D-glucuronide, 5 mg | sc-222192 | 5 mg | $498.00 |